In vitro combinations of five intravenous antibiotics with Dalfopristin-Quinupristin against staphylococcus aureus in a 3-dimensional model

Journal of Chemotherapy

Volumn 20, Issue 6, 2008, Pages 684-689

  Duez, Jean Marie ^a   Adochitei, A ^a   Pechinot A ^a   Siebor, E ^a   Sixt, N ^a   Neuwirth, C ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

Antibiotic combination; Dalfopristin; Fosfomycin; Gentamicin; Quinupristin; Rifampin; Staphylococcus aureus; Tigecycline; Vancomycin

Indexed keywords

ANTIBIOTIC AGENT; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; FOSFOMYCIN; GENTAMICIN; METICILLIN; PENICILLIN G; RIFAMPICIN; TIGECYCLINE; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG POTENTIATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; STAPHYLOCOCCUS AUREUS; THREE DIMENSIONAL IMAGING;

EID: 59349111204     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2008.20.6.684     Document Type: Article

References (16)

1. Comité de l'antibiogramme de la Société Française de Microbiologie: recommandations 2007. Downloaded from internet: http://www.sfm.asso.fr/
2. Batard E, Jacqueline C, Boutoille D et al. Combination of quinupristin-dalfopristin and gentamicin against methicillin-resistant Staphylococcus aureus: experimental rabbit endocarditis study. Antimicrob Agents Chemother 2002; 46 (7): 2174-2178.
3. Duez JM, Cordin X, Siebor E, Péchinot A, Chamard-Neuwirth C, Kazmierczak A. [A three-dimensional model to study a combination of three antibiotics in vitro. Application to the bactericidal activity of piperacillin, tazobactam and amikacin against five strains of enterobacteria according to their beta-lactam resistance pattern] (in French). Path Biol 1998;46(1):67-72.
4. Eliopoulos GM, Eliopoulos CT. Antibiotic combinations: should they be tested? Clin Microbiol Rev 1988; 1 (2): 139-156.
5. Kang LS, Rybak MJ. Pharmocodynamics of RP 59500 alone and in combination with vancomycin against Staphylococcus aureus in an in vitro-infected fibrin clot model. Antimicrob Agents Chemother 1995; 39 (7): 1505-1511.
6. Odds FC - Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 2003; 52:1
7. Allen GP, Cha R, Rybak MJ. In vitro activities of quinupristin-dalfopristin and cefepime, alone and in combination with various antimicrobials, against multidrug-resistant Staphylococci and Enterococci in an in vitro pharmacodynamic model. Antimicrob Agents Chemother 2002; 46 (8): 2606-2612.
8. Fuchs PC, Barry AL, Brown SD. Interactions of quinupristin-dalfopristin with eight other antibiotics as measured by time-kill studies with 10 strains of Staphylococcus aureus for which quinupristin-dalfopristin alone was not bactericidal. Antimicrob Agents Chemother 2001; 45 (9): 2662-2665.
9. Grif K, Dierich MP, Pfaller K, Miglioli PA, Allerberger F. In vitro activity of fosfomycin in combination with various antistaphylococcal substances. J Antimicrob Chemother 2001; 48: 209-217.
10. Kang LS, Rybak MJ. In-vitro bactericidal activity of quinupristin/ dalfopristin alone and in combination against resistant strains of Enterococcus species and Staphylococcus aureus. J Antimicrob Chemother 1997; 39: Suppl. A, 33-39.
11. Pavie J, Lefort A, Zarrouk V, et al. Efficacies of quinupristin-dalfopristin combined with vancomycin in vitro and in experimental endocarditis due to methicillin-resistant Staphylococcus aureus in relation to cross-resistance to macrolides, lincosamides, and streptogramin B-type antibiotics. Antimicrob Agents Chemother 2002; 46 (9): 3061-3064.
12. Sambatakou H, Giamarellos-Bourboulis EJ, Grecka P, Chryssouli Z, Giamarellou H. In-vitro activity and killing effect of quinupristin/ dalfopristin (RP 59500) on nosocomial Staphylococcus aureus and interactions with rifampicin and ciprofloxacin against methicillin-resistant isolates. J Antimicrob Chemother 1998; 41: 349-355.
13. Zarrouk V, Bozdogan B, Leclercq R, et al. Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics. Antimicrob Agents Chemother 2001; 45 (4): 1244-1248. Erratum, 2001, 45 (6), 1941.
14. Duez JM, Kohli E, Péchinot A, Bryskier A, Kazmierczak A - In vitro activity of the combination tetracycline-erythromycin against bacterial strains responsive of respiratory tract infections] (in French). Lyon Médical 1985; 253 (4): 119-121.
15. Berenbaum MC. A method for testing for synergy with any number of agents. J Infect Dis 1978; 137 (2): 122-130.
16. Yu VL, Felegie TP, Yee RB, Pasculle AW, Taylor FH. Synergistic interaction in vitro with use of three antibiotics simultaneously against Pseudomonas maltophilia. J Infect Dis 1980; 142 (4): 602-607.